Fredrik Pontén
Professor vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerprecisionsmedicin; Forskargrupp Fredrik Pontén
- Telefon:
- 018-611 38 46
- Mobiltelefon:
- 070-309 23 42
- E-post:
- fredrik.ponten@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
- Akademiska meriter:
- DMSc, docent
Mer information visas för dig som medarbetare om du loggar in.
Biografi
Denna text finns inte på svenska, därför visas den engelska versionen.
Fredrik Ponten, MD, PhD, is Professor at Uppsala University and a board-certified specialist of Anatomical Pathology at the Uppsala University Hospital. He is the Vice-Program Director and Clinical Director of the Human Protein Atlas program, and heads the Human Protein Atlas effort at the Uppsala site. His research is based on an affinity proteomics approach with emphasis on translational medicine. Dr Ponten who is a former Fulbright schollar, is one of the founders of the Human Protein Atlas program and a member of the Atlas Antibodies AB Board. Dr Ponten received his PhD from Uppsala University in 1996, he did a post-doc at Yale University (New Haven, CT, USA) and became full professor in 2008 at the Department of Immunology, Genetics and Pathology, Uppsala University, Sweden.
Publikationer
Urval av publikationer
- A subcellular map of the human proteome (2017)
- A pathology atlas of the human cancer transcriptome (2017)
- Expression of Human Skin-Specific Genes Defined by Transcriptomics and Antibody-Based Profiling (2015)
- Tissue-based map of the human proteome (2015)
- A systematic analysis of commonly used antibodies in cancer diagnostics (2014)
- The Human Protein Atlas as a proteomic resource for biomarker discovery (2011)
Senaste publikationer
- Effect of preoperative chemotherapy on the histopathological classification of gastric cancer (2024)
- The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer (2024)
- Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine Tumors (2024)
- CD93 maintains endothelial barrier function and limits metastatic dissemination (2024)
- A human stomach cell type transcriptome atlas (2024)
Alla publikationer
Artiklar
- Effect of preoperative chemotherapy on the histopathological classification of gastric cancer (2024)
- The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer (2024)
- Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine Tumors (2024)
- CD93 maintains endothelial barrier function and limits metastatic dissemination (2024)
- A human stomach cell type transcriptome atlas (2024)
- Next generation pan-cancer blood proteome profiling using proximity extension assay (2023)
- Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer (2023)
- Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma (2023)
- An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers (2023)
- Imaging of fibrogenesis in the liver by [18F]TZ-Z09591, an Affibody molecule targeting platelet derived growth factor receptor β (2023)
- Combined expression of HOXA11 and CD10 identifies endometriosis versus normal tissue and tumors (2022)
- Genome-wide annotation of protein-coding genes in pig (2022)
- A human adipose tissue cell-type transcriptome atlas (2022)
- Endothelial cell heterogeneity and microglia regulons revealed by a pig cell landscape at single-cell level (2022)
- Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer (2021)
- ELTD1-deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma. (2021)
- A single-cell type transcriptomics map of human tissues (2021)
- Spatiotemporal dissection of the cell cycle with single-cell proteogenomics (2021)
- The Immune Landscape of Colorectal Cancer (2021)
- The prognostic impact of the tumour stroma fraction (2021)
- The noncoding MIR100HG RNA enhances the autocrine function of transforming growth factor beta signaling (2021)
- Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis (2021)
- CDX2 (2020)
- Proximity Ligation Assay as a Tool for Antibody Validation in Human Tissues (2020)
- Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy (2020)
- Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis (2020)
- An atlas of the protein-coding genes in the human, pig, and mouse brain (2020)
- Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy (2020)
- Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors (2019)
- LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer (2019)
- Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC (2019)
- Quantification and discovery of sequence determinants of protein-per-mRNA amount in 29 human tissues (2019)
- Systematic assessment of antibody selectivity in plasma based on a resource of enrichment profiles (2019)
- Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer (2019)
- Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib (2019)
- The human secretome (2019)
- A genome-wide transcriptomic analysis of protein-coding genes in human blood cells (2019)
- A deep proteome and transcriptome abundance atlas of 29 healthy human tissues (2019)
- Immunohistochemistry for transcription factor T-Pit as a tool in diagnostics of corticotroph pituitary tumours (2018)
- Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer (2018)
- U-CAN (2018)
- Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma (2018)
- Mining the Human Tissue Proteome for Protein Citrullination (2018)
- Novel Multiomics Profiling of Human Carotid Atherosclerotic Plaques and Plasma Reveals Biliverdin Reductase B as a Marker of Intraplaque Hemorrhage (2018)
- In situ protein detection with enhanced specificity using DNA-conjugated antibodies and proximity ligation (2018)
- The human adrenal gland proteome defined by transcriptomics and antibody-based profiling (2017)
- A nonsense mutation in CEP55 defines a new locus for a Meckel-like syndrome, an autosomal recessive lethal fetal ciliopathy. (2017)
- Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence (2017)
- Principles of Systems Biology, No. 21 (2017)
- Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas (2017)
- Breast cancer in young women and prognosis (2017)
- A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma (2017)
- Reaching the limits of prognostication in non-small cell lung cancer (2017)
- Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction in EGFR, pEGFR, and pSrc. (2017)
- Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients (2017)
- Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib (2017)
- Serglycin as a potential biomarker for glioma (2017)
- Mast Cell Infiltration in Human Brain Metastases Modulates the Microenvironment and Contributes to the Metastatic Potential (2017)
- High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer (2017)
- A specific antibody to detect transcription factor T-Pit (2017)
- A subcellular map of the human proteome (2017)
- A pathology atlas of the human cancer transcriptome (2017)
- Analysis of Body-wide Unfractionated Tissue Data to Identify a Core Human Endothelial Transcriptome. (2016)
- Profiling cancer testis antigens in non-small-cell lung cancer (2016)
- Gene-specific correlation of RNA and protein levels in human cells and tissues (2016)
- A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression (2016)
- Long-term outcome in young women with breast cancer (2016)
- SATB2 is expressed in Merkel cell carcinoma (2016)
- GPR44 is a pancreatic protein restricted to the human beta cell (2016)
- ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer (2016)
- Oncogene-Induced Senescence in Pituitary Adenomas-an Immunohistochemical Study. (2016)
- Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer (2016)
- Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer (2016)
- System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue Homeostasis (2016)
- PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status. (2016)
- Visualization and analysis of gene expression in tissue sections by spatial transcriptomics (2016)
- Transcriptomics resources of human tissues and organs (2016)
- The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene (2016)
- Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages (2016)
- Extension of diffuse low-grade gliomas beyond radiological borders as shown by the coregistration of histopathological and magnetic resonance imaging data (2016)
- High levels of WNT-5A in human glioma correlate with increased presence of tumor-associated microglia/monocytes (2015)
- The Crux of Molecular Prognostications in NSCLC (2015)
- The Identification of Therapeutic Targets in Lung Cancer Based on Transcriptomic and Proteomic Characterization of Cancer-Testis Antigens (2015)
- Expression of Human Skin-Specific Genes Defined by Transcriptomics and Antibody-Based Profiling (2015)
- Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma (2015)
- A prognosis based classification of undifferentiated uterine sarcomas (2015)
- The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling. (2015)
- The Urinary Bladder Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling (2015)
- Tumor Vessel Up-Regulation of INSR Revealed by Single-Cell Expression Analysis of the Tyrosine Kinome and Phosphatome in Human Cancers (2015)
- Elevated Expression of the C-Type Lectin CD93 in the Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function and Reduce Host Survival (2015)
- The human cardiac and skeletal muscle proteomes defined by transcriptomics and antibody-based profiling (2015)
- ALK Rearrangements in Non-Small Cell Lung Cancer (2015)
- Prognostic impact of COX-2 in non-small cell lung cancer (2015)
- Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer (2015)
- A Tissue-Based Map of the Human Proteome (2015)
- Foxf2 Is Required for Brain Pericyte Differentiation and Development and Maintenance of the Blood-Brain Barrier (2015)
- Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells (2015)
- Defining the Human Brain Proteome Using Transcriptomics and Antibody-Based Profiling with a Focus on the Cerebral Cortex (2015)
- FGF2 as a potential prognostic biomarker for proneural glioma patients (2015)
- High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort (2015)
- Tissue-based map of the human proteome (2015)
- Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR (2015)
- Complementing tissue characterization by integrating transcriptome profiling from the Human Protein Atlas and from the FANTOM5 consortium (2015)
- Pleiotrophin promotes vascular abnormalization in gliomas and correlates with poor survival in patients with astrocytomas. (2015)
- The Human Endometrium-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling (2015)
- Antibody performance in western blot applications is context-dependent (2014)
- Affinity proteomics within rare diseases (2014)
- Decreased decorin expression in the tumor microenvironment (2014)
- The Human Pancreas Proteome Defined by Transcriptomics and Antibody-Based Profiling (2014)
- Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling (2014)
- The human testis-specific proteome defined by transcriptomics and antibody-based profiling (2014)
- The role of SATB2 as a diagnostic marker for tumors of colorectal origin (2014)
- A study of embryonic stem cell-related proteins in human astrocytomas (2014)
- Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics (2014)
- Detection of the human endogenous retrovirus ERV3-encoded Env-protein in human tissues using antibody-based proteomics (2014)
- Breast cancer in young women - age a risk factor only in those not given chemotherapy (2014)
- A systematic analysis of commonly used antibodies in cancer diagnostics (2014)
- The Kidney Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling (2014)
- Evidence for a morphologically distinct and functionally robust cell type in the proximal tubules of human kidney (2014)
- Detection of enterovirus in the islet cells of patients with type 1 diabetes (2014)
- Antibody validation of immunohistochemistry for biomarker discovery (2014)
- Defining the human gallbladder proteome by transcriptomics and affinity proteomics (2014)
- The human liver-specific proteome defined by transcriptomics and antibody-based profiling (2014)
- Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade (2014)
- Molecular- and organelle-based predictive paradigm underlying recovery by left ventricular assist device support (2014)
- The lung-specific proteome defined by integration of transcriptomics and antibody-based profiling (2014)
- Analysis of Candidate Genes for Lineage-Specific Expression Changes in Humans and Primates (2014)
- Defining the Human Adipose Tissue Proteome To Reveal Metabolic Alterations in Obesity (2014)
- Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer (2014)
- Investigation of molecular alterations of AKT-3 in triple-negative breast cancer (2014)
- Garbage in, garbage out (2014)
- Peroxiredoxin-1 protects estrogen receptor alpha from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer (2014)
- Subtyping of gliomas of various WHO grades by the application of immunohistochemistry (2014)
- Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner (2014)
- WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism (2014)
- PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas (2014)
- Antibodies Biotinylated Using a Synthetic Z-domain from Protein A Provide Stringent In Situ Protein Detection (2013)
- Biomarker discovery in non-small cell lung cancer (2013)
- Novel signatures of cancer-associated fibroblasts (2013)
- CDK-mediated activation of the SCFFBXO28 ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer (2013)
- Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model (2013)
- Estrogen receptor expression induces changes in the microRNA pool in human colon cancer cells (2013)
- Contribution of Antibody-based Protein Profiling to the Human Chromosome-centric Proteome Project (C-HPP) (2013)
- Improving the Diagnosis and Management of Neuroendocrine Tumors (2013)
- In situ Protein Detection for Companion Diagnostics (2013)
- Enteroviruses and the pathogenesis of type 1 diabetes revisited (2013)
- Identifying Prognostically Relevant Subsets of Endometrial Cancer Using Unsupervised Clustering of Immunohistochemical Staining Data (2013)
- Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma (2013)
- Heart Research Advances Using Database Search Engines, Human Protein Atlas and the Sydney Heart Bank (2013)
- European H16N3 Gull Influenza Virus Attaches to the Human Respiratory Tract and Eye (2013)
- The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer (2013)
- Expression of the actin-binding protein Anillin is a prognostic biomarker for primary ER positive breast cancer. (2013)
- Foxf2 in Intestinal Fibroblasts Reduces Numbers of Lgr5(+) Stem Cells and Adenoma Formation by Inhibiting Wnt Signaling (2013)
- Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer (2013)
- Profiling of Atherosclerotic Lesions by Gene and Tissue Microarrays Reveals PCSK6 as a Novel Protease in Unstable Carotid Atherosclerosis (2013)
- A Texture Based Pattern Recognition Approach to Distinguish Melanoma from Non-Melanoma Cells in Histopathological Tissue Microarray Sections (2013)
- Vandetanib combined with a p38 MAPK inhibitor synergistically reduces glioblastoma cell survival (2013)
- The protein phosphatase 2 subunit PR48 is a novel melanoma tumor suppressor gene. (2013)
- Increased expression of heparanase in symptomatic carotid atherosclerosis (2013)
- Antibodies for profiling the human proteome (2012)
- Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression (2012)
- Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization (2012)
- CD99 is a novel prognostic stromal marker in non-small cell lung cancer (2012)
- A tool to facilitate clinical biomarker studies - a tissue dictionary based on the Human Protein Atlas (2012)
- Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas (2012)
- Scalable In Situ Hybridization on Tissue Arrays for Validation of Novel Cancer and Tissue-Specific Biomarkers (2012)
- The interactome of LIM domain proteins (2012)
- Novel pancreatic beta cell-specific proteins (2012)
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients (2012)
- SATB2 is an Independent Predictor of Outcome in Colorectal Cancer (2012)
- Peroxiredoxin-1 Protects Against Oncogene-induced Suppression of the Estrogen Receptor and is a Biomarker of Favourable Prognosis in Estrogen Receptor-positive Breast Cancer (2012)
- BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain (2012)
- CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression (2012)
- TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression (2012)
- GABA-A Channel Subunit Expression in Human Glioma Correlates with Tumor Histology and Clinical Outcome (2012)
- Antibody-based Protein Profiling of the Human Chromosome 21 (2012)
- Paladin (X99384) is expressed in the vasculature and shifts from endothelial to vascular smooth muscle cells during mouse development (2012)
- Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen (2011)
- RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer (2011)
- Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice (2011)
- Large-Scale Protein Profiling in Human Cell Lines Using Antibody-Based Proteomics (2011)
- Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma (2011)
- High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer (2011)
- Generation of monospecific antibodies based on affinity capture of polyclonal antibodies (2011)
- Diagnostic biomarkers of prostate cancer (2011)
- GAD1 is a biomarker for benign and malignant prostatic tissue (2011)
- Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma (2011)
- SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas (2011)
- The Human Protein Atlas as a proteomic resource for biomarker discovery (2011)
- Sun-Induced Nonsynonymous p53 Mutations Are Extensively Accumulated and Tolerated in Normal Appearing Human Skin (2011)
- Growth differentiation factor 15 (2011)
- SOX10 expression in superficial spreading and nodular malignant melanomas (2010)
- Profiling protein expression and interactions (2010)
- Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer (2010)
- Antibody-based proteomics (2010)
- Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer (2010)
- Tissue-specific protein expression in human cells. tissues end organs (2010)
- Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy (2010)
- International network of cancer genome projects (2010)
- Antibody-based proteomics for discovery and exploration of proteins expressed in pancreatic islets (2010)
- The impact of tissue fixatives on morphology and antibody-based protein profiling in tissues and cells (2010)
- Topoisomerase I Amplification in Melanoma is Associated with More Advanced Tumours and Poor Prognosis (2010)
- Toward Next Generation Plasma Profiling via Heat-induced Epitope Retrieval and Array-based Assays (2010)
- Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer (2010)
- Towards a knowledge-based Human Protein Atlas (2010)
- Pulmonary Autoimmunity as a Feature of Autoimmune Polyendocrine Syndrome Type 1 and Identification of KCNRG as a Bronchial Autoantigen (2009)
- Approaching clinical proteomics (2009)
- Approaching clinical proteomics (2009)
- Intercalated discs (2009)
- High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer (2009)
- The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer (2009)
- Correlations between RNA and protein expression profiles in 23 human cell lines (2009)
- Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer (2009)
- ZBED6, a novel transcription factor derived from a domesticated DNA transposon regulates IGF2 expression and muscle growth (2009)
- Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer (2009)
- A global view of protein expression in human cells, tissues, and organs (2009)
- DLG3/SAP102 protein expression in malformations of cortical development (2009)
- Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy (2009)
- Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma (2009)
- Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas (2009)
- Herbal melanin activates TLR4/NF-kappaB signaling pathway (2009)
- Expression profiling of microdissected cell populations selected from basal cells in normal epidermis and basal cell carcinoma (2008)
- Toward a confocal subcellular atlas of the human proteome (2008)
- A genecentric Human Protein Atlas for expression profiles based on antibodies (2008)
- A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues (2008)
- The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas (2008)
- Serological and immunohistochemical analysis of S100 and derivatives as markers for prognosis of newly operated malignant melanoma patients (2008)
- HMG-CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors (2008)
- Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer (2008)
- The correlation between cellular size and protein expression levels--normalization for global protein profiling (2008)
- Evaluation of monospecific antibodies (2008)
- A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse (2008)
- The Human Protein Atlas (2008)
- Transcriptional profiling of melanocytes from patients with vitiligo vulgaris (2008)
- Sox10 Has a Broad Expression Pattern in Gliomas and Enhances Platelet-Derived Growth Factor-B–Induced Gliomagenesis (2007)
- The RBCC Gene RFP2 (Leu5) Encodes a Novel Transmembrane E3 Ubiquitin Ligase Involved in ERAD (2007)
- In Situ Identification of Genes Regulated Specifically in Fibroblasts of Human Basal Cell Carcinoma (2007)
- Systematically generated antibodies against human gene products (2007)
- A high-throughput strategy for protein profiling in cell microarrays using automated image analysis (2007)
- Analysis of protein expression in cell microarrays (2006)
- From gene expression analysis to tissue microarrays (2006)
- Effect of herbal melanin on IL-8 (2006)
- Biobanking of fresh frozen tissue (2006)
- Genetic tumor archeology (2005)
- Laser-assisted cell microdissection using the PALM system. (2005)
- Towards a human proteome atlas (2005)
- Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays (2005)
- A human protein atlas for normal and cancer tissues based on antibody proteomics (2005)
- Antibody-based proteomics for human tissue profiling. (2005)
- The role of p53 codon 72 and human papilloma virus status of cutaneous squamous cell carcinoma in the Swedish population. (2004)
- Antibody-based tissue profiling as a tool for clinical proteomics (2004)
- A fluid cover medium provides superior morphology and preserves RNA integrity in tissue sections for laser microdissection and pressure catapulting (2004)
- Enhanced epidermal ultraviolet responses in chronically sun-exposed skinare dependent on previous sun exposure. (2003)
- Zinc-based fixative improves preservation of genomic DNA and proteins in histoprocessing of human tissues. (2003)
- Similar UV responses are seen in a skin organ culture as in human skin in vivo (2002)
- Rapid increase in diagnosis of cutaneous melanoma in situ in Sweden 1968-1992 (1998)
- Reconstruction of the two-dimensional distribution of p53 positive staining patches in sun-exposed morphologically normal skin (1997)
- Elevated levels of the human endogenous retrovirus ERV3 in human sebaceous glands (1996)
- Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis (1996)
- Extending the immune phenotypes of lung cancer: Oasis in the desert
- Angiogenesis as a risk factor for young women with breast cancer
- Prognostic whole-genome and transcriptome signatures in colorectal cancers
Kapitel
Konferenser
- Expression of podocalyxin-like protein and epidermal growth factor receptor in metastatic colorectal cancer: Prognostic impact and relationship with response to cetuximab. (2018)
- Prognostic significance of SATB1 expression in metastatic colorectal cancer: A Nordic prospective cohort study. (2018)
- Automated Analysis of Human Protein Atlas Immunofluorescence Images (2009)